NATX Plasmids, for: DNA Vaccines, Gene Therapeutics, Viral Vectors andBiophamacueticals

Proteins
NTC's Rcombinant Protein Production Sevices and Technologies

Site Map

NTC Homepage

Vectors
XServices
XPricing
XManuals

Hyper-Taq™ DNA Polymerase

DNA Vaccines
XRapidVACC™
XVersatile Targeting Vectors
XDNAVACC-Ultra™

Proteins:
XRecombinant Proteins
XpVEX™
XFluorescent Proteins

Plasmids
XSmall Scale Plasmid DNA
XSmall Scale C of A
XLarge Scale Plasmid DNA
XLarge Scale C of A
XPlasmid DNA Order Form
XE. coli Cell Paste
X
DNA Fermentation Process
XHyperGRO™ Process
XHyperGRO™ Licensing
XHyperGRO™ Prices

Process Development
XProcess Development Basics
XProcess Licensing

Research and Development
XTechnologies
XPublications
XPatents
XPress Releases
XPartnering Opportunities

Corporate Profile
XManagement Team
XBoard of Directors
XInvestor Information

Contact Us
XScientific Meetings
XEmployment

Recombinant proteins are rapidly becoming a major industry within biologics, topping $63 billion in 2007 ($39 billion in the U.S. alone), and are anticipated to grow to $87 billion by 2010[i].


NTC is a leading industrial supplier of highest quality, economical, fluorescent recombinant proteins, which are increasingly needed for flow cytometry, confocal microscopy, laser scanning microscopy, immunoconjugates, etc. As more fluorescent proteins are discovered in unique aquatic and rain-forest environments, their uses multiply, making production an art as much as a science.

NTC has devised a unique overall approach to recombinant protein production, which involves careful consideration of design elements and processing steps affecting the product. The result is a superb product: pure, stable, and highly active, manufactured using NTC's pVEX™ E. coli recombinant system (vectors, strains, and processes) .

[i]Daniels, D., (2008) Refining Protein Drug Formulation, Genetic Eng. News 28(16)1-50.


XXXCase Study: pVEX™: E. coli Protein expression system


NTC designed marker proteins for diagnostics, including elements for purification and labeling. pVEX™ fermentation and downstream process developed at 2g/L (soluble protein) and transferred to commercial production on behalf of customers.

NTC's production technology pVEX™ (E. coli expression system) combines record breaking yields, careful maturation
ease of chemical conjugation and ultra purification, resulting in the highest quality immunology-grade reagents.

NTC’s pVEX Suite™ is a combination of process, vectors, IP, know-how and trade secrets enabling record yields of 20g/L of recombinant proteins, from E. coli host cells. Obviously, higher yields reduce the cost of goods, increase ROI, and improve final product purity.



pVEX™ fluorescent proteins expressed in a leaky strain illustrate potential 20 g/l production

XXFluorescent proteins, Biomarkers and Biosensors

Fluorescent proteins, biomarkers and biosensors have never been hotter. Now, the hottest protein expression system, pVEX™, has been harnessed to create the new intergalactic standard for quality and ingenuity in the maturation and purification of fluorescent chromophores. These are not prepackaged products, but rather are the result of careful design and manufacturing of custom products, ranging from flow cytometry to specialized devices. NTC's process engineers and molecular scientists make the right solutions happen for you in the highest quality immunology-grade reagents.


NTC offers its industry partners a variety of options, including:

XContract recombinant protein design, development, and production services
XX
XLicensing pVEX™ technolgy

Contact NTC, Toll free: 1-(888) WIZ-Bang

Plasmids, Recombinant Proteins, DNA Vaccines, Viral Vectors, Therapeutic Genes, Fermentation Technology for Gene Therapy and Biotechnology
NTC's free resource "Site" for the biotechnology industry,
including Databases and Sequences Analysis Tool
s



WWW http://www.natx.com